{"doi":"10.1016/j.cmet.2022.10.004","title":"An emerging direction in glucagon-based therapy","abstract":null,"journal":"Cell Metabolism","year":2022,"id":643293,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":173247,"name":"Dehua Yang","orcid":null,"position":1,"is_corresponding":false},{"id":173249,"name":"Ming-Wei Wang","orcid":null,"position":2,"is_corresponding":false},{"id":1307176,"name":"Yan Chen","orcid":"0000-0002-0600-7583","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"An emerging direction in glucagon-based therapy","abstract":"Glucagon receptor (GCGR) is an essential regulator of hepatic metabolism. In this issue of Cell Metabolism, Sekar et al. report that the endosomal protein Vps37a uncouples hepatic glucose production from lipid metabolism by altering the intracellular localization of GCGR, thereby providing a new potential therapeutic direction for type 2 diabetes.","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36323231","pmcid":null,"openalex_id":"https://openalex.org/W4308037639","authors":[],"funders":[],"total_grants":0,"fwci":0.4202,"citation_percentile":0.6252409,"influential_citations":0,"citation_trend":[{"year":2024,"count":1},{"year":2025,"count":1}],"oa_status":"closed","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S1550413122004557?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1550413122004557?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.cmet.2022.10.004","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36323231","host_type":"repository"}],"fields_of_study":["Pancreatic function and diabetes","Diabetes Treatment and Management","Receptor Mechanisms and Signaling","Humans","Glucagon","Diabetes Mellitus, Type 2","Receptors, Glucagon","Liver","Glucose"],"mesh_terms":["Diabetes Mellitus, Type 2","Glucagon","Glucose","Humans","Liver","Receptors, Glucagon"],"keywords":["Glucagon receptor","Regulator","Cell metabolism","Glucagon","Endosome","Intracellular","Lipid metabolism","Glucagon-like peptide-1","Metabolism","Carbohydrate metabolism","Receptor","Biology","Cell biology","Diabetes mellitus","Type 2 diabetes","Endocrinology","Insulin","Biochemistry","Gene"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-08T15:12:38.954844Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}